Navigation Links
BioGenex and Abbott Molecular Conclude Successful Partnership
Date:3/4/2013

FREMONT, Calif., March 4, 2013 /PRNewswire/ -- After a long and successful collaboration and partnership, BioGenex and Abbott Molecular have announced that BioGenex will take over direct sales and support responsibility for co-branded Xmatrx instruments, auto FISH reagents and consumables, with immediate effect.

Xmatrx FISH, the product of successful partnership, enabled walk-away automation of all assay steps required to perform Abbott's FISH tests from baking to final cover slip, providing ready-to-view slides.

BioGenex will support current Xmatrx customers, and if desired by the customers, will enable their Xmatrx system to perform other slide based assays e.g. IHC, ISH, SS, and miRNA in addition to FISH.

"Abbott and BioGenex are working closely and are committed to ensure seamless transition. Hospitals, labs, and research institutions that use Xmatrx can be assured that they will get best in class service and support. BioGenex and Abbott representatives have jointly advised the customers of this change. "The transition to the next phase of our relationship is a testament to the truly unique capabilities of the Xmatrx platform, which allows automation of molecular pathology staining assays, from microtome to microscope," said Dr. Krishan Kalra , CEO, BioGenex.

About Xmatrx® ELITE
Xmatrx® ELITE is an integrated system consisting of a platform technology for full automation for any slide based assay e.g. IHC, ISH, SS, miRNA & FISH. This truly All-in-One fully automated system from microtome to microscope maximizes the testing capacity, minimizes hands-on time, and ensures consistent and quality results every time.

Xmatrx® ELITE enabled with specially formulated and optimized reagents, including primary antibodies, nucleic acid probes, special stains, detection kits and consumables delivers optimum performance yet is cost effective for total automation. This underlies our commitment to provide flexible work flow solutions for today, tomorrow and beyond.

About us [www.biogenex.com]
BioGenex designs, develops, and commercializes advanced fully-automated Molecular Diagnostic Systems for cancer diagnosis, prognosis, therapy selection, personalized medicine, and life science research. Our products include fully automated instruments, Nucleic Acid probes, Antibodies, detection systems, ancillary reagents, and consumables to provide the total solution for ISH, CISH, IHC, SS, FISH, and in Situ PCR. Our customer focused approach, with premier after-sales support and excellent technical service, provides the best-in-class customer care. Our spirit of innovation drives us to deliver cutting edge technology, years ahead of our competition, and the finest reagents and instruments for life Science research and diagnostics.

Visit BioGenex @ USCAP 2013 | Booth No. 130 | Mar.04-Mon to Mar.06-Wed, 2013 | Baltimore Convention Center | USA

Media Contact:

Saba Ammari, 5108241400, s.ammari@biogenex.com

USA Office: T: +1-510-824-1400 | F: +1-510-824-1490 | Toll Free: 1-[800] 421-4149 | 49026 Milmont Drive Fremont CA 94538 | U.S.A.

India Office : T: +91-40-27185500 | F: +91-40-27185511/21 | 225 Cherlapally - Industrial Development Area - Phase II Hyderabad, AP | India 500051


'/>"/>
SOURCE BioGenex
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Abaxis Announces Exclusive Distribution Agreement with Abbott
2. Abbott Sued for False Claims Related to its Blockbuster Drug TriCor
3. Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.
4. Abbott, The Abbott Fund And Direct Relief International Reach Key HIV Testing Milestones: 20 Million Tests Provided Over 10 Years, And More Than 150,000 HIV Cases Prevented In Children
5. Abbott Presents Results of Clinical Studies Evaluating Its Investigational Treatment for Advanced Parkinsons Disease
6. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
7. Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India
8. BiOptix announces expansion of Innovators Program at Molecular Med TRI-CON 2013
9. Global Market for Molecular Diagnostics to Exceed $10.7 Billion by 2018, Regenerative Medicine to Top $4.4 Billion
10. Trovagene to Introduce First Urine-Based Molecular Diagnostic Test for Transrenal Cancer Mutation Monitoring
11. DioGenix and Fast Forward Collaborate to Develop Blood-Based Molecular Diagnostic for Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... -- The Board of Directors of J M Smith Corporation ... new CEO and Chairman of the Board, effective March ... CEO William R. Cobb .  Turfe was selected ... a wealth of experience in the life sciences, medical ... a pool of incredibly qualified candidates, Alan demonstrated the ...
(Date:3/1/2017)... 1, 2017 Lo stesso sistema sara, visibile nello stand ... Paramed Medical Systems sta installando la settima unità MROpen in Gran ... nuovo centro dell,European Scanning Center (ESC) a Cardiff. ESC attualmente gestisce altri due ... Continue Reading ... ...
(Date:2/28/2017)... Prefilled Syringes Market: Scope and Segmentation ... This report provides a forecast and analysis of ... regional levels. It provides historical data of 2015 ... terms of revenue (US$ Mn) and volume (Bn ... with an outlook on prefilled syringes consumption globally. ...
Breaking Medicine Technology:
(Date:3/1/2017)... ... March 01, 2017 , ... NYC based Integrated practice Living Well Medical, a ... the addition of Orthopaedic Surgeon Dr. Donald E. Heitman. Dr. Heitman is ... with a Bachelor of Science degree in biology. He then obtained his medical degree ...
(Date:3/1/2017)... ... March 01, 2017 , ... “There is Comfort for the Soul”: a ... author in their all-too-brief time together, and the soul-healing comfort provided by God’s presence ... creation of published author, Jerie A. Tau, a dog-loving medical professional whose work takes ...
(Date:3/1/2017)... ... March 01, 2017 , ... “Marriage...God's Way: Key To One Flesh”: ... To One Flesh” is the creation of published author Cecilia Chiam, a writer who ... Cecilia Chiam‘s new book presents solutions to many marital problems with the guidance ...
(Date:3/1/2017)... Colo. (PRWEB) , ... March 01, 2017 , ... ... to the marijuana industry, today unveiled its Cannabis Compliance Program for Regulatory Agencies. ... medical marijuana industry to provide regulators with internal or outsourced compliance program options, ...
(Date:2/28/2017)... DC (PRWEB) , ... March 01, 2017 , ... Among ... the National League for Nursing, Beverly Malone, PhD, RN, FAAN, has been tapped ... Healthcare, a prestigious biennial list compiled by the Modern Healthcare. She will join her ...
Breaking Medicine News(10 mins):